清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

ERCC1 as Relevant Targets in the DNA Repair Pathway

作者
Jean‐Charles Soria,David Planchard,Ken André Olaussen,Pierre Jean Fouret
出处
期刊:Molecular Cancer Therapeutics [American Association for Cancer Research]
卷期号:6 被引量:1
摘要

PL02-04 Today, cisplatin (and its analogs, carboplatin and oxaliplatin) remain the scaffolding of chemotherapy in many solid tumors including lung, head and neck, bladder, ovarian, and colon carcinomas. After several decades of clinical trials, a therapeutic plateau has been reached using standard chemotherapy in most solid tumors. A re-evaluation of strategies to improve clinical outcomes is needed.
 The DNA repair mechanism is one of the crucial molecular pathways potentially involved in resistance to platin-based chemotherapy. Alkylating agents such as platinum components form DNA-adducts that induce DNA lesions that are directly responsible for the cytotoxicity. The excision repair cross-complementation group 1 (ERCC1) is a highly conserved nuclease in mammals that performs the excision of these cytotoxic DNA-adducts during a process called Nucleotide Excision Repair (NER). The ERCC1 gene is one of the 16 genes that encode the proteins of the NER complex and together with its XP group F (XPF) partners, performs an essential late step in the NER process responsible for the 5-prime incision. Many cancer cells have the ability to resist against the effects of chemotherapy through increased capacity of DNA-repair, in particular through the activation of the NER pathway due to high levels of ERCC1. NER functions by a cut-and-paste mechanism in which cisplatin damage recognition, local opening of the DNA helix around the lesion, damage lesion and gap-filling occur in successive steps.
 Numerous studies have reported the importance of ERCC1 expression in the repair mechanism of cisplatin-induced DNA adducts in human ovarian cancer cells, in primary gastric tumors, in colorectal and esophageal cancer. ERCC1 mRNA ? expression has been negatively associated with response to cisplatin or oxaliplatin chemotherapy in gastric and colon cancer. High tumor tissue levels of ERCC1 mRNA in ovarian and gastric cancer patients have been associated with cisplatin resistance. Recently, ERCC1 protein expression was studied in resected NSCLC tumors from 761 patients from the International Adjuvant Lung Trial (IALT). Patients with ERCC1 negative tumors who were randomized to chemotherapy had significantly prolonged survival compared to those who were randomized to observation (test for interaction, P

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
复杂鸵鸟完成签到,获得积分10
5秒前
浮生若梦完成签到,获得积分10
6秒前
18秒前
eagletyr完成签到 ,获得积分10
18秒前
笔墨纸砚完成签到 ,获得积分10
18秒前
光亮的幻桃完成签到,获得积分10
28秒前
37秒前
hy完成签到,获得积分10
39秒前
nano完成签到 ,获得积分10
48秒前
RZH发布了新的文献求助10
57秒前
机智的如曼完成签到,获得积分10
1分钟前
Xzx1995完成签到 ,获得积分10
1分钟前
FashionBoy的应助被科研通管家采纳,获得10
1分钟前
fairytaler的应助被科研通管家采纳,获得10
1分钟前
现代的初之完成签到,获得积分10
1分钟前
大模型的应助被蜗牛好好飞采纳,获得10
1分钟前
ChatGPT完成签到,获得积分10
1分钟前
慕青的应助被蜗牛好好飞采纳,获得10
1分钟前
夏同学完成签到 ,获得积分10
1分钟前
今后的应助被蜗牛好好飞采纳,获得10
1分钟前
wwrjj完成签到,获得积分0
1分钟前
搜集达人的应助被cc采纳,获得10
1分钟前
大模型的应助被蜗牛好好飞采纳,获得10
1分钟前
1分钟前
1分钟前
御坂10576号完成签到,获得积分10
1分钟前
1分钟前
义气的雅琴完成签到,获得积分10
1分钟前
cc发布了新的文献求助10
1分钟前
NexusExplorer的应助被蜗牛好好飞采纳,获得10
1分钟前
Harlotte完成签到 ,获得积分0
1分钟前
蒋不惜完成签到,获得积分10
1分钟前
changfox完成签到,获得积分10
1分钟前
hyk完成签到 ,获得积分10
1分钟前
milalala完成签到 ,获得积分10
2分钟前
浚稚完成签到 ,获得积分10
2分钟前
2分钟前
冷傲的夜白完成签到,获得积分10
2分钟前
岳晓燕完成签到 ,获得积分10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173230
求助须知:如何正确求助?哪些是违规求助? 9565593
关于积分的说明 21780525
捐赠科研通 7767429
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555764
邀请新用户注册赠送积分活动 2476697